Loading data
CTSNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 541.32 m USD | 514.76 m USD | 550.42 m USD | 586.87 m USD | 512.93 m USD |
| Cost of revenue | 333.29 m USD | 327.2 m USD | 359.56 m USD | 376.33 m USD | 328.31 m USD |
| Gross profit | 208.03 m USD | 187.56 m USD | 190.86 m USD | 210.54 m USD | 184.62 m USD |
| Research and development expense | 25.27 m USD | 23.39 m USD | 24.92 m USD | 24.1 m USD | 23.86 m USD |
| Selling, general and administrative expense | 98.72 m USD | 88.29 m USD | 83.82 m USD | 91.52 m USD | 82.6 m USD |
| Operating profit | 82.64 m USD | 71.19 m USD | 75.05 m USD | 93.01 m USD | 76.48 m USD |
| Interest expense | — | — | 3.33 m USD | 2.19 m USD | 2.11 m USD |
| Profit before tax | 83.77 m USD | 68.58 m USD | 75.15 m USD | 80.74 m USD | -60.88 m USD |
| Income tax expense | 18.45 m USD | 13.11 m USD | 14.62 m USD | 21.16 m USD | -19.01 m USD |
| Net income (reported basis) | 63.64 m USD | 58.1 m USD | 60.5 m USD | 59.6 m USD | -41.9 m USD |
| Basic earnings per share | 2.21 USD/share | 1.82 USD/share | 1.93 USD/share | 1.86 USD/share | -1.3 USD/share |
| Diluted earnings per share | 2.19 USD/share | 1.81 USD/share | 1.92 USD/share | 1.85 USD/share | -1.3 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.